These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 11273490)

  • 1. Adverse drug reaction reporting and monitoring: role of practising physicians.
    Bhatia RS; Sibia SS
    J Assoc Physicians India; 2000 Aug; 48(8):852. PubMed ID: 11273490
    [No Abstract]   [Full Text] [Related]  

  • 2. Adverse drug reaction monitoring in India.
    Kshirsagar NA; Karande SC; Potkar CN
    J Assoc Physicians India; 1993 Jun; 41(6):374-6. PubMed ID: 8005977
    [No Abstract]   [Full Text] [Related]  

  • 3. Monitoring for adverse drug events.
    Kennedy DL; Goldman SA
    Am Fam Physician; 1997 Nov; 56(7):1718, 1721. PubMed ID: 9371003
    [No Abstract]   [Full Text] [Related]  

  • 4. Reporting of adverse drug reactions: predictors of under-reporting in Malaysia.
    Aziz Z; Siang TC; Badarudin NS
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):223-8. PubMed ID: 16947117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adverse effects of dental materials. Important that also physicians report].
    Swartling PG
    Lakartidningen; 1999 Jul; 96(30-31):3329. PubMed ID: 10459239
    [No Abstract]   [Full Text] [Related]  

  • 6. [Important that physicians perform quality assurance of drug treatment of elderly].
    Asberg KH
    Lakartidningen; 2007 Jan 10-16; 104(1-2):40-3. PubMed ID: 17323740
    [No Abstract]   [Full Text] [Related]  

  • 7. Call for spontaneous reports of adverse drug events from Indian physicians--need of the hour.
    Gogtay NJ; Kshirsagar NA
    J Assoc Physicians India; 2007 Aug; 55():597-8. PubMed ID: 18019806
    [No Abstract]   [Full Text] [Related]  

  • 8. [Reporting of side-effects--a system in need of improvement. Reporting of a physician questionnaire].
    Ekbom Y; Hedenmalm K; Dalin L; Lönnroth K; Persson I
    Lakartidningen; 2002 Aug; 99(34):3290-5. PubMed ID: 12362847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of the Danish Medical Products Agency in clinical trials].
    Simonsen AC
    Ugeskr Laeger; 2003 Apr; 165(16):1653-6. PubMed ID: 12756821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual and severe forms of adverse drug reactions.
    Gogtay N; Mangalvedhekar S; Kshirsagar NA
    J Assoc Physicians India; 1999 Aug; 47(8):847. PubMed ID: 10778648
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacists' role in reporting adverse drug reactions in an international perspective.
    van Grootheest K; Olsson S; Couper M; de Jong-van den Berg L
    Pharmacoepidemiol Drug Saf; 2004 Jul; 13(7):457-64. PubMed ID: 15269929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The flip side of Ayurveda.
    Thatte UM; Rege NN; Phatak SD; Dahanukar SA
    J Postgrad Med; 1993; 39(4):179-82, 182a-182b. PubMed ID: 7996491
    [No Abstract]   [Full Text] [Related]  

  • 13. Reporting of adverse drug reactions and physician liability.
    Witmer DR; Liang FZ
    Am J Hosp Pharm; 1992 Mar; 49(3):538, 544. PubMed ID: 1598918
    [No Abstract]   [Full Text] [Related]  

  • 14. [The role of the user in vigilance management].
    Mérillon MC
    Transfus Clin Biol; 2005 Jun; 12(2):191-9. PubMed ID: 15922643
    [No Abstract]   [Full Text] [Related]  

  • 15. Improving drug safety monitoring.
    Karande S; Gogtay NJ; Kshirsagar NA
    Indian Pediatr; 2003 Dec; 40(12):1167-75. PubMed ID: 14722367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward improved adverse event/suspected adverse drug reaction reporting.
    Gross R; Strom BL
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):89-91. PubMed ID: 12642971
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of private practitioners in tuberculosis control in India.
    Grover NK
    J Indian Med Assoc; 1996 Oct; 94(10):370-1. PubMed ID: 9141874
    [No Abstract]   [Full Text] [Related]  

  • 18. [The Medical Products Agency is responsible for the control of medical technological products: we need more active medical professionals reporting shortages].
    Philipson L
    Lakartidningen; 2008 Mar 5-11; 105(10):746-7. PubMed ID: 18422241
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse drug reaction monitoring in India.
    Bhatia RS
    J Assoc Physicians India; 1994 Mar; 42(3):265. PubMed ID: 7860537
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new system for drug control in the EEC. Role of Sweden in an active monitoring of adverse effects].
    Wiholm BE; Beermann B; Strandberg K
    Lakartidningen; 1995 Jan; 92(3):129-32. PubMed ID: 7837842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.